Eric Kelsic

Eric Kelsic is a prominent figure in the field of gene therapy, known for his groundbreaking work at Dyno Therapeutics where he serves as the Founder and CEO. He is a trailblazer in the application of artificial intelligence and machine learning to revolutionize gene therapy, specifically focusing on AAV capsid engineering.

Educationally, Eric holds a Doctor of Philosophy (PhD) in Systems Biology from Harvard University and a Bachelor of Science (BS) in Physics with Honors from the California Institute of Technology (Caltech).

Throughout his career, Eric has held various key positions including Staff Scientist at the Lab of George Church at Wyss Institute for Biologically Inspired Engineering, Postdoctoral Research Fellow at the Lab of George Church at Harvard Medical School, and Graduate Student at the Lab of Roy Kishony at Harvard University. He has also worked as an English Instructor at Nankai University and gained research experience in Chemical Engineering at the Smolke Lab at Caltech.

Eric's vast experience includes roles as a Puzzle Box Inventor through his self-employment, as well as stints as a Summer Undergraduate Research Fellow at both Caltech, working with Mason Porter, and at the National Institute of Standards and Technology. His diverse background highlights his expertise in AAV Gene Therapy, High-throughput Synthetic Biology, Machine Learning, Software Engineering, and Alliance Management.

Currently, Eric Kelsic and his team at Dyno Therapeutics are actively seeking professionals in the fields of AAV Gene Therapy, High-throughput Synthetic Biology, Machine Learning, Software Engineering, and Alliance Management. To learn more about their innovative work, visit www.dynotx.com.